Oral Methotrexate Solution Step Therapy
Customize your policy alerts
Sign up for all simplyhealthcare policy alerts
Know when simplyhealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs authorization for Jylamvo and Xatmep oral methotrexate solutions under Simply Healthcare's step therapy program. Coverage for these Step 2 products requires the patient to have tried oral methotrexate sodium as the Step 1 drug.
No material clinical or coverage changes in this revision.
Jylamvo and Xatmep Coverage Criteria
Jylamvo and Xatmep Step Therapy
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.